5-[3-(5-oxo-4H-[1,2,4]oxadiazol-3-yl)phenyl]-1H-naphtho[1,2-b][1,4]diazepine-2,4(3H,5H)-dione | 1239578-78-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯二氮卓类
• 英文名称: 5-[3-(5-oxo-4H-[1,2,4]oxadiazol-3-yl)phenyl]-1H-naphtho[1,2-b][1,4]diazepine-2,4(3H,5H)-dione
• 英文别名: 5-[3-(5-oxo-4H-[1,2,4]oxadiazol-3-yl)phenyl]-1H-naphtho[1,2-b][1,4]diazepin-2,4(3H,5H)-dione；5-[3-(5-oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]-1H-benzo[g][1,5]benzodiazepine-2,4-dione
• CAS: 1239578-78-9
• 化学式: C₂₁H₁₄N₄O₄
• 分子量: 386.367
• InChiKey: OVFQCMGLZBSLNR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  29
• 可旋转键数：
  2
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.05
• 拓扑面积：
  100
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  3-((1-nitronaphthalen-2-yl)amino)benzonitrile 在 palladium 10% on activated carbon 吡啶 、 盐酸羟胺 、 氢气 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 、 甲苯 为溶剂， 反应 8.25h， 生成 5-[3-(5-oxo-4H-[1,2,4]oxadiazol-3-yl)phenyl]-1H-naphtho[1,2-b][1,4]diazepine-2,4(3H,5H)-dione
  参考文献：
  名称：

  DIAZEPINEDIONE DERIVATIVE

  摘要：

  公开号：

  EP2397480B1

文献信息

• Diazepinedione derivative
  申请人：Nippon Chemiphar Co., Ltd.

  公开号：US08778933B2

  公开（公告）日：2014-07-15

  A diazepinedione derivative represented by the formula (I) or a pharmacologically acceptable salt thereof is used as a P2X4 receptor antagonist: wherein R1 represents a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, or the like, R2 and R3 represent a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, a halogen atom, or the like, R4 and R5 represent a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, or the like, and W represents tetrazole or the like.

  公式（I）所代表的一种二氮杂环二酮衍生物或其药学上可接受的盐被用作P2X4受体拮抗剂：其中R1代表氢原子，1至8个碳原子的烷基或类似物，R2和R3代表氢原子，1至8个碳原子的烷基，卤素原子或类似物，R4和R5代表氢原子，1至8个碳原子的烷基或类似物，W代表四唑或类似物。
• DRUG FOR TREATING COUGH
  申请人：Nippon Chemiphar Co., Ltd.

  公开号：EP3766497A1

  公开（公告）日：2021-01-20

  The present invention pertains to a medicament for preventing or treating cough, including, as an active ingredient, a compound having P2X4 receptor antagonistic action, a tautomer, stereoisomer, or pharmaceutically acceptable salt of the compound, or a hydrate or solvate thereof.

  本发明涉及一种预防或治疗咳嗽的药物，其活性成分包括具有 P2X4 受体拮抗作用的化合物、该化合物的同分异构体、立体异构体或药学上可接受的盐，或其水合物或溶液。
• MEDICAMENT FOR TREATING COUGH
  申请人：NIPPON CHEMIPHAR CO., LTD.

  公开号：US20210000840A1

  公开（公告）日：2021-01-07

  The present invention pertains to a medicament for preventing or treating cough, including, as an active ingredient, a compound having P2X4 receptor antagonistic action, a tautomer, stereoisomer, or pharmaceutically acceptable salt of the compound, or a hydrate or solvate thereof.
• MEDICAMENT FOR TREATMENT OF MULTIPLE SCLEROSIS
  申请人：NIPPON CHEMIPHAR CO., LTD.

  公开号：US20210121478A1

  公开（公告）日：2021-04-29

  A medicament for preventive and/or therapeutic treatment of multiple sclerosis, especially a pain accompanying multiple sclerosis such as neuropathic pain, which contains a compound having a P2X4 receptor antagonist activity such as a compound represented by the general formula (IH), or a salt thereof, or a hydrate or solvate thereof as an active ingredient.
• US8470814B2
  申请人：——

  公开号：US8470814B2

  公开（公告）日：2013-06-25